3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
17
Colorectal Neoplasms
15
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Skin Neoplasms
4
Rectal Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Neoplasm Metastasis
2
Gastrointestinal Neoplasms
2
Digestive System Neoplasms
2
Thyroid Neoplasms
1
Solid Tumors
1
Skin Diseases
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Lymphatic Metastasis
1
Leukemia, Hairy Cell
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Gastrointestinal Diseases
1
Disease Progression
1
Digestive System Diseases
1
Colonic Diseases
1
Biliary Tract Neoplasms
1
Interventions
Temozolomide
100
Radiotherapy
49
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
22
Bevacizumab
22
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
10
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
encorafenib
×
1 year
×
Clear all
No trials found.